Portfolio (Quarterly)
Guide ↗
Rhenman & Partners Asset Management AB
· CIK 0001599882| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | UNH | UNITED HEALTH GROUP INC | Healthcare | 93,600.0 | $38.9M | 3.67% | +48K | +105.7% | $415.63 | -7.2% |
| 2 | CVS | CVS HEALTH CORP | Healthcare | 279,374.0 | $28.9M | 2.73% | -57K | -17.0% | $103.45 | -9.1% |
| 3 | AZN | ASTRAZENECA PLC | Healthcare | 151,500.0 | $28.5M | 2.69% | NEW | — | $187.99 | -12.4% |
| 4 | MRK | MERCK & CO INC | Healthcare | 213,500.0 | $27.4M | 2.59% | NEW | — | $128.50 | +17.2% |
| 5 | LLY | LILLY ELI & CO | Healthcare | 22,315.0 | $26.8M | 2.53% | -11K | -33.8% | $1199.43 | +4.3% |
| 6 | ABBV | ABBVIE INC | Healthcare | 96,775.0 | $24.4M | 2.30% | +25K | +35.2% | $251.64 | +4.9% |
| 7 | ALHC | ALIGNMENT HEALTHCARE INC | Healthcare | 997,083.0 | $23.7M | 2.24% | -56K | -5.3% | $23.81 | -46.2% |
| 8 | EW | EDWARDS LIFESCIENCES CORP | Healthcare | 260,000.0 | $23.5M | 2.22% | +97K | +59.5% | $90.46 | -0.1% |
| 9 | GILD | GILEAD SCIENCES INC | Healthcare | 178,250.0 | $22.5M | 2.13% | +10K | +6.3% | $126.34 | +14.6% |
| 10 | JAZZ | JAZZ PHARMACEUTICALS PLC | Healthcare | 87,440.0 | $21.1M | 1.99% | +12K | +15.2% | $240.97 | +2.5% |
| 11 | BIIB | BIOGEN INC | Healthcare | 94,850.0 | $20.5M | 1.93% | -14K | -13.1% | $216.06 | +0.0% |
| 12 | SYK | STRYKER CORPORATION | Healthcare | 65,000.0 | $20.5M | 1.93% | +17K | +36.0% | $314.84 | +5.3% |
| 13 | BSX | BOSTON SCIENTIFIC CORP | Healthcare | 450,500.0 | $19.2M | 1.81% | -174K | -27.9% | $42.68 | +16.5% |
| 14 | JNJ | JOHNSON & JOHNSON | Healthcare | 72,500.0 | $18.4M | 1.74% | NEW | — | $253.97 | +6.0% |
| 15 | GH | GUARDANT HEALTH INC | Healthcare | 115,000.0 | $17.3M | 1.63% | -30K | -20.7% | $150.03 | +13.4% |
| 16 | REGN | REGENERON PHARMACEUTICALS | Healthcare | 27,390.0 | $17.1M | 1.61% | -21K | -43.1% | $623.54 | +33.5% |
| 17 | GKOS | GLAUKOS CORP | Healthcare | 119,000.0 | $16.6M | 1.57% | +35K | +41.7% | $139.76 | +32.2% |
| 18 | BMRN | BIOMARIN PHARMACEUTICAL INC | Healthcare | 290,500.0 | $16.6M | 1.57% | +84K | +40.3% | $57.22 | +19.0% |
| 19 | NRIX | NURIX THERAPEUTICS INC | Healthcare | 684,250.0 | $16.6M | 1.57% | +371K | +118.3% | $24.26 | +11.7% |
| 20 | NTRA | NATERA INC | Healthcare | 61,050.0 | $16.6M | 1.56% | +9K | +18.3% | $271.45 | +20.1% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
99.6%
Technology
0.4%